Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities
Armata Pharmaceuticals, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial […]
FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production
FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serum-free and chemically […]
JanOne Completes Acquisition of Soin Therapeutics
JanOne, a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced […]
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators
AbbVie and Anima Biotech (Anima) today announced a collaboration to discover and develop mRNA biology modulators […]
Quanterix Announces Appointment of Brian Blaser to Board of Directors
Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it […]
Genethon Launches Pivotal Clinical Trial of Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease
Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association […]
Vector BioPharma and iBET Collaborate to Develop High-throughput Analytical Methods and Scalable Processes for Gene Delivery
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and […]
Gensaic Receives Funding From the CF Foundation to Develop a Gene Therapy for People With Cystic Fibrosis
Gensaic, a company that seeks to reimagine gene therapy, has announced that it has received […]
Clarivate Identifies Fifteen Potential Blockbuster Drugs in Annual Drugs to Watch Report
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of […]
Alira Health Accelerates Global Growth and Secures Additional $58M in Funding
Alira Health, a global healthcare advisory, clinical research and technology company, announced it secured an […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more